Search research articles
Contact Us
Filters
Showing results (1101-1110 of 1,298) with videos related to
Page
of 130
Sort By:
JCO Precision Oncology
|
July 24, 2018
Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer
Funda Meric-Bernstam, Xiaofeng Zheng, Maryam Shariati, et al.
Cancer Discovery
|
November 4, 2011
ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer
Todd W Miller, Justin M Balko, Emily M Fox, et al.
Gynecologic Oncology Reports
|
April 18, 2022
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
Elizabeth H Stover, Niya Xiong, Andrea P Myers, et al.
Cell Reports. Medicine
|
October 8, 2021
<i>CCNE1</i> copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models
Haineng Xu, Erin George, Yasuto Kinose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer
Janos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
NPJ Breast Cancer
|
October 23, 2018
Molecular determinants of post-mastectomy breast cancer recurrence
Kimberly S Keene, Tari King, E Shelley Hwang, et al.
Molecular Cell
|
May 27, 2014
Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation
Ge Zhou, Jiping Wang, Mei Zhao, et al.
Oncogene
|
February 3, 2015
Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer
E G Seviour, V Sehgal, Y Lu, et al.
Biorxiv : the Preprint Server for Biology
|
February 3, 2025
Neoplastic immune mimicry potentiates breast tumor progression
Eric B Berens, Sokchea Khou, Elaine Huang, et al.
Nature Metabolism
|
January 28, 2020
Characterization of Hypoxia-associated Molecular Features to Aid Hypoxia-Targeted Therapy
Youqiong Ye, Qingsong Hu, Hu Chen, et al.
Page
of 130
Search research articles
Search
Showing results (1101-1110 of 1,298) with videos related to
Sort By:
Page
of 130
JCO Precision Oncology
|
July 24, 2018
Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer
Funda Meric-Bernstam, Xiaofeng Zheng, Maryam Shariati, et al.
Cancer Discovery
|
November 4, 2011
ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer
Todd W Miller, Justin M Balko, Emily M Fox, et al.
Gynecologic Oncology Reports
|
April 18, 2022
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
Elizabeth H Stover, Niya Xiong, Andrea P Myers, et al.
Cell Reports. Medicine
|
October 8, 2021
<i>CCNE1</i> copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models
Haineng Xu, Erin George, Yasuto Kinose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer
Janos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
NPJ Breast Cancer
|
October 23, 2018
Molecular determinants of post-mastectomy breast cancer recurrence
Kimberly S Keene, Tari King, E Shelley Hwang, et al.
Molecular Cell
|
May 27, 2014
Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation
Ge Zhou, Jiping Wang, Mei Zhao, et al.
Oncogene
|
February 3, 2015
Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer
E G Seviour, V Sehgal, Y Lu, et al.
Biorxiv : the Preprint Server for Biology
|
February 3, 2025
Neoplastic immune mimicry potentiates breast tumor progression
Eric B Berens, Sokchea Khou, Elaine Huang, et al.
Nature Metabolism
|
January 28, 2020
Characterization of Hypoxia-associated Molecular Features to Aid Hypoxia-Targeted Therapy
Youqiong Ye, Qingsong Hu, Hu Chen, et al.
Page
of 130